Now in its second year, this Free to Breathe grant is focused on research to systematically investigate interventions or strategies to increase clinical trial accrual to therapeutic lung cancer clinical trials. For 2016, we are supporting one award of $100,000, paid over two years.
Our goal is to fund pilot research projects that will investigate novel strategies to improve accrual of patients with lung cancer to therapeutic clinical trials by at least 50% within a defined healthcare facility, system, or community. Proposals must have a clear vision about how the pilot project, if successful, can be an expanded to other institutions for validation of the intervention or strategy. The intent of Free to Breathe is to fund projects that will be reproducible and implementable to a wider community.
We anticipate that the winner will be announced by the end of 2016. Thank you to everyone who submitted an application for the Free to Breathe Accelerate Clinical Trials (ACT) Research Grant.
If you have questions about the Research Grant competition, please contact:
Mary F. Henningfield, PhD
Director Scientific Education and Research, Free to Breathe
©2017 Free To Breathe | All rights reserved. | Federal tax exempt ID number: 45-0505050.